This is where the cancer has spread to the bones, resulting in a great deal of pain in most cases. This is usually Stage 5. Death is not far off at this point. With chemotherapy, the person may get 18 to 24 more months of life. Without chemo, an 8 to 9 month life expectancy is all that is left.
Radium-223 chloride (Xofigo) is a radioactive drug used to treat prostate cancer that has spread to the bones. It works by delivering targeted radiation directly to bone metastases, which helps reduce pain and improve overall survival in patients with advanced prostate cancer. Radium-223 can help improve quality of life by reducing bone pain and delaying the progression of the disease.
When cancer spreads, the new sites are called metastases.
Prostate Cancer originates in the Male Prostate, however it can metastasize, or spread to other areas of the body.
Late stage prostate cancer metasticizes to the bones. This may be the reason.
Hahahaahahahaha you have cancer
Prostate cancer can spread to the bone, liver and lung and other parts of body. In most cases of prostate cancer metastasis occur in the lymph nodes and the bones. It's metastasis occurs when cells break away from the tumor in the prostate. nutrition2000.com
Bone marrow transplants are not typically used as a primary treatment for prostate cancer. However, they may be considered in specific cases, such as when prostate cancer has spread and affected the bone marrow, or in conjunction with certain high-dose chemotherapy regimens. The primary treatments for prostate cancer usually include surgery, radiation therapy, hormone therapy, and chemotherapy. It's essential for patients to discuss their individual cases with healthcare professionals to determine the most appropriate treatment options.
When any type of cancer metastasizes and spreads to the bone or other organs, this is very serious. Only a trained doctor who looks at the pathology of patient who has cancer that has spread to the bone can make such a diagnosis.
When prostate cancer spreads to other parts of the body, such as the bones, the acid phosphatase levels may increase. Acid phosphatase is an enzyme that can be elevated in cases of bone metastasis from prostate cancer, as it is released by prostate cancer cells in the bones. Monitoring acid phosphatase levels can help in assessing the extent of metastasis and response to treatment.
The prostate is a small gland in men. It is part of the male reproductive system. Prostate hardening is caused by the development of cancer in the prostate. As cancer develops the tissue of prostate changes texture and hardness. symptoms of prostate cancer may include blood in the urine or semen, problems with erections, loss of bladder control, and bone pain in the lower back, hips or ribs. nutrition2000.com
The prognosis for prostate cancer that has spread to the bones, known as metastatic prostate cancer, varies widely depending on several factors, including the extent of the spread, response to treatment, and overall health of the individual. In general, the average survival rate for metastatic prostate cancer is around 3-5 years. However, with advancements in treatment options such as hormone therapy, chemotherapy, and targeted therapies, some individuals may live longer than this average, while others may have a shorter lifespan. It is important for individuals with prostate bone cancer to work closely with their healthcare team to determine the most appropriate treatment plan for their specific situation.
Healthy Body Healthy Mind - 2003 Advanced Prostate Cancer and Bone Loss 16-2 was released on: USA: 8 April 2010